Health China

Today's News Popular Stories
Page: 2








Genentech's silver lining
The FDA's rejection of Avastin as a treatment for breast cancer was certainly a setback, but the drug giant may yet prevail.
Read More | 0 Comments












<<< previous next >>>
Biotech China 2014
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.